Speaker illustration

Professor Gregory Marcus

UCSF Health, San Francisco (United States of America)

Member of:

European Society of Cardiology

Greg Marcus is Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chief of Cardiology for Research at UCSF Health, and Endowed Professor of Atrial Fibrillation Research. He completed his internship, residency, and served as Chief Medical Resident at Stanford. He completed his general cardiology and cardiac electrophysiology fellowships at UCSF. As part of an NIH-funded career development award, he then completed a Masters in Advanced Studies in Clinical Research at UCSF. He has published more than 350 peer-reviewed research articles, served on the writing committee of the recent AHA/ ACC/ HRS Management of Atrial Fibrillation guidelines, is the Chair Elect of the American Heart Association’s Committee on Drugs, Alcohol, and Tobacco, is an Associate Editor at JAMA, and has been elected to the Association of University Cardiologists and American Society of Clinical Investigation. He is a practicing EP and oversees multiple research programs.

Excess morbidity and mortality associated with seasonal influenza in patients with atrial fibrillation

Date: 5 November 2025

Journal: European Heart Journal

Thumbnail

Coffee and cardiovascular disease

Date: 8 July 2025

Journal: European Heart Journal

Thumbnail

Illicit stimulants and ventricular arrhythmias: a longitudinal cohort study

Date: 7 May 2025

Journal: European Heart Journal

Thumbnail

Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

Date: 30 July 2024

Journal: EP Europace Journal

Thumbnail

Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation

Date: 9 April 2024

Journal: European Heart Journal - Quality of Care and Clinical Outcomes

Thumbnail

Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities

Date: 5 July 2023

Journal: European Heart Journal

Thumbnail

Lifestyle habits associated with cardiac conduction disease

Date: 20 January 2023

Journal: European Heart Journal

Thumbnail

Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation

Date: 18 October 2022

Journal: European Heart Journal

Thumbnail

Predictors of atrial ectopy and their relationship to atrial fibrillation risk

Date: 6 March 2019

Journal: EP Europace Journal

Thumbnail

ESC 365 is supported by